Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011:2011:301850.
doi: 10.1155/2011/301850. Epub 2011 Sep 21.

Proliferative tumor doubling times of prostatic carcinoma

Priya N Werahera  1 , L Michael Glode, Francisco G La Rosa, M Scott Lucia, E David Crawford, Kenneth Easterday, Holly T Sullivan, Rameshwar S Sidhu, Elizabeth Genova, Tammy Hedlund
Affiliations

Proliferative tumor doubling times of prostatic carcinoma

Priya N Werahera et al. Prostate Cancer. 2011.

Abstract

Prostate cancer (PCa) has a variable biology ranging from latent cancer to extremely aggressive tumors. Proliferative activities of cancers may indicate their biological potential. A flow cytometric assay to calculate maximum proliferative doubling times (T(max)) of PCa in radical prostatectomy specimens after preoperative in vivo bromodeoxyuridine (BrdU) infusion is presented. Only 4/17 specimens had tumors large enough for flow cytometric analysis. The T(max) of tumors was similar and ranged from 0.6 to 3.6 months. Tumors had calculated doubling times 2- to 25-fold faster than their matched normal tissue. Variations in labeling index and T(max) were observed within a tumor as well as between different Gleason grades. The observed PSA doubling times (PSA-DT) ranged from 18.4 to 32.0 months, considerably slower than the corresponding T(max) of tumors involved. While lack of data for apoptotic rates is a limitation, apparent biological differences between latent versus aggressive PCa may be attributable to variations in apoptotic rates of these tumors rather than their cell proliferative rates.

PubMed Disclaimer

Figures

Figure 1
Figure 1
(a) Histogram 1: auxiliary peak red fluorescence versus red fluorescence, and (b) histogram 2: BrdU-FITC green fluorescence versus propidium iodide red fluorescence.
Figure 2
Figure 2
Gleason pattern 3 carcinoma with BrdU incorporated into the DNA of dividing cells (magnification 40X).
Figure 3
Figure 3
Distribution of BrdU incorporated cell nuclei within Gleason pattern 4 glands (magnification 100X).
See this image and copyright information in PMC

References

    1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer Journal for Clinicians. 2010;60(5):277–300. - PubMed
    1. Miller GJ, Cygan JM. Morphology of prostate cancer: the effects of multifocality on histological grade, tumor volume and capsule penetration. Journal of Urology. 1994;152(5):1709–1713. - PubMed
    1. Sakr WA, Grignon DJ, Crissman JD, et al. High grade prostatic intraepithelial neoplasia (HGPIN) and prostatic adenocarcinoma between the ages of 20–69: an autopsy study of 249 cases. In Vivo. 1994;8(3):439–443. - PubMed
    1. Crawford ED, Hirano D, Werahera PN, et al. Computer modeling of prostate biopsy: tumor size and location—not clinical significance—determine cancer detection. Journal of Urology. 1998;159(4):1260–1264. - PubMed
    1. Hirano D, Werahera PN, Crawford ED, Lucia MS, DeAntoni EP, Miller GJ. Morphological analysis and classification of latent prostate cancer using a 3-dimensional computer algorithm: Analysis of tumor volume, grade, tumor doubling time and life expectancy. Journal of Urology. 1998;159(4):1265–1269. - PubMed